From NAFLD to MASLD: implications of the new nomenclature for preclinical and clinical research

被引:0
|
作者
Cynthia L. Hsu
Rohit Loomba
机构
[1] University of California at San Diego,Division of Gastroenterology and Hepatology, Department of Medicine
[2] VA San Diego Healthcare System,Department of Medicine
[3] University of California at San Diego,MASLD Research Center, Division of Gastroenterology and Hepatology, Department of Medicine
[4] University of California at San Diego,The Herbert Wertheim School of Public Health and Human Longevity Science
来源
Nature Metabolism | 2024年 / 6卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Non-alcoholic liver disease (NAFLD) is now metabolic dysfunction-associated steatotic liver disease (MASLD), emphasizing the key metabolic factors of obesity, insulin resistance, vascular dysfunction and dyslipidaemia. Here, we discuss impacts on the existing body of clinical and preclinical liver disease research and on research moving forward.
引用
收藏
页码:600 / 602
页数:2
相关论文
共 50 条
  • [31] NAFLD vs MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease)-Why the Need for a Change of Nomenclature?
    Gastaldelli, Amalia
    Newsome, Philip N.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2025,
  • [32] Cytochrome P450: New nomenclature and clinical implications
    Cupp, MJ
    Tracy, TS
    AMERICAN FAMILY PHYSICIAN, 1998, 57 (01) : 107 - 116
  • [33] Deciphering the implications of MAFLD and MASLD definitions in the NAFLD population: results from a single-center biopsy study
    Kaya Eda
    Yilmaz Yusuf
    中华医学杂志英文版, 2024, 137 (05)
  • [34] The new hepatic steatosis nomenclature. No more NAFLD!
    Castro-Narro, G. E.
    Rinella, M. E.
    REVISTA DE GASTROENTEROLOGIA DE MEXICO, 2024, 89 (02):
  • [35] Deciphering the implications of MAFLD and MASLD definitions in the NAFLD population: results from a single-center biopsy study
    Kaya, Eda
    Yilmaz, Yusuf
    CHINESE MEDICAL JOURNAL, 2024, 137 (05) : 616 - 618
  • [36] IMPACT OF NEW NOMENCLATURE ON HOSPITALIZATION OUTCOMES: COMPARING MASLD, METALD, AND ALD
    Franco, Gian Rodriguez
    Sollenberger, Christopher
    Massie, Tammy
    Hsu, Christine
    HEPATOLOGY, 2024, 80 : S833 - S834
  • [37] From NAFLD to MAFLD and MASLD: a tale of alcohol, stigma and metabolic dysfunction
    Ciardullo, Stefano
    Perseghin, Gianluca
    METABOLISM AND TARGET ORGAN DAMAGE, 2024, 4 (04):
  • [38] From NAFLD to MASLD: transforming steatotic liver disease diagnosis and management
    Iruzubieta, Paula
    Jimenez-Gonzalez, Carolina
    Crespo, Javier
    Cabezas, Joaquin
    METABOLISM AND TARGET ORGAN DAMAGE, 2025, 5 (01):
  • [39] Can we use old NAFLD data under the new MASLD definition?
    Song, Sherlot Juan
    Lai, Jimmy Che-To
    Lai-Hung, Jimmy Grace
    Wai-Sun, Vincent
    Yip, Terry Cheuk-Fung
    JOURNAL OF HEPATOLOGY, 2024, 80 (02) : e54 - e56
  • [40] NAFLD: genetics and its clinical implications
    Sharma, Dixa
    Mandal, Palash
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2022, 46 (09)